Cancer Chemotherapy Treatment; All You Need To Now About Himalayan Fungus | A special type of fungus growing in the Himalayas will cure cancer, it is up to 40% effective, know how it works | NewsBust Cancer Chemotherapy Treatment; All You Need To Now About Himalayan Fungus | A special type of fungus growing in the Himalayas will cure cancer, it is up to 40% effective, know how it works | NewsBust

Health

Cancer Chemotherapy Treatment; All You Need To Now About Himalayan Fungus | A special type of fungus growing in the Himalayas will cure cancer, it is up to 40% effective, know how it works

By Ankit Sharma - October 11, 2021

feature img

2 minutes ago

  • copy link

Cancer can be treated with a fungus found in the Himalayas. This fungus is scientifically called Cordyceps sinensis. It has the ability to fight cancer and stop cancerous cells. This has also been proved in the joint research of Oxford University and Biopharma company Newkana.

What is this fungus, how will it help in the treatment of cancer and why is it special, know the answers to these questions…

What is this fungus, first understand it?
It is a fungus found in the Himalayas. It has been used for hundreds of years in the preparation of Chinese medicine. It is also called caterpillar fungus. It is found especially in the Nepal and Bhutan part of the Himalayas. Cordypsin and adenosine chemicals are found in it. Codycepsin is the biggest feature of this fungus. This is the reason why this fungus has been given the status of medicinal mushroom in Chinese medicine. the

Now know, how will this cure cancer?

From this fungus, scientists have developed a drug that will be used as a chemotherapy drug. The drug is named NUC-7738. It has been found during research that it is an anti-cancer drug, that is, it has the ability to defeat cancer. It helps prevent cancer cells and is up to 40 percent effective.

According to researchers, the chemical cordypsin found in the fungus reaches the body and starts dissolving in the blood. It is broken down with the help of an enzyme called ADA. After this, it shows its effect by reaching the cancer cells. This has also been proved in initial clinical trials.

Phase I trial successful
According to a study published in the journal Clinical Cancer Research, the drug company Nukana is using this drug under the name NUC-7738. The results of clinical trial phase-1 have been effective. Preparations are being made for Phase-2 of the clinical trial. Soon the next phase of trial will be done on a large scale.

14 lakh cancer patients in the country: ICMR

According to the Indian Council of Medical Research (ICMR), there are 13.9 lakh cancer patients in the country. By 2025, their number can increase to 15.7 lakh.

Cancer cases were reported in 6,79,421 Indian men in 2020. This figure may reach 7,63,575 by 2025. At the same time, in 2020, 7,12,758 women were troubled by cancer. By 2025, these cases may reach 8,06,218. The ICMR report says, by 2025, breast cancer will become the most common cancer of this disease. In second place will be lung cancer.

There is more news…

Trending Stories

Ankit Sharma